Patent · US Active

Crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide

US12018020B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Intervet Inc. · US

Inventors

Christophe Pierre Alain Chassaing · Ingelheim am Rhein, DE
Xiaoling Jin · Green Brook, US
Rositza Iordanova Petrova · Metuchen, US
Richard J. Varsolona · Scotch Plains, US
Lorenzo Codan · Olten, CH
Edward Cleator · Cambridge, GB
Adrian Goodyear · Buntingford, GB
Jonathan Simmons · Ware, GB
Tanja Schweisel · Arbach, DE

Key dates

Filing date	Dec 12, 2019
Grant date	Jun 25, 2024
Priority date	—
Expiry date	Jul 20, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl) amino]pyrazole-4-carboxamide and processes for the preparation thereof. The compound is useful for the treatment of JAK-mediated diseases or conditions such as atopic dermatitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.